CDK12 and CDK13 in oncology: from RNA regulation to therapeutic targeting
Cellular Oncology · 2026
DOI: 10.1007/s13402-025-01131-z ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cellular Oncology, 2026. Verfasst von Julia Dudkiewicz-Garbicz und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Histology and Embryology, Medical University of Warsaw, Warsaw, Poland. julia_dudkiewicz@dfci.harvard.edu. Hauptthemen laut MEDLINE: Cyclin-Dependent Kinases, Neoplasms, Molecular Targeted Therapy. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 110 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Histology and Embryology, Medical University of Warsaw, Warsaw, Poland. julia_dudkiewicz@dfci.harvard.edu.
- Harvard Medical School, Boston, MA, USA. julia_dudkiewicz@dfci.harvard.edu.
- Department of Pediatric Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA. julia_dudkiewicz@dfci.harvard.edu.
- Department of Histology and Embryology, Medical University of Warsaw, Warsaw, Poland. pawel.wlodarski@wum.edu.pl.
Zitieren
APA
Dudkiewicz-Garbicz, J., & Włodarski, P. K. (2026). CDK12 and CDK13 in oncology: from RNA regulation to therapeutic targeting. Cellular Oncology. https://doi.org/10.1007/s13402-025-01131-z
Vancouver
Dudkiewicz-Garbicz J, Włodarski PK. CDK12 and CDK13 in oncology: from RNA regulation to therapeutic targeting. Cellular Oncology. 2026. doi:10.1007/s13402-025-01131-z
BibTeX
@article{DudkiewiczGarbicz2026,
author = {Dudkiewicz-Garbicz, Julia and Włodarski, Paweł K},
title = {CDK12 and CDK13 in oncology: from RNA regulation to therapeutic targeting},
journal = {Cellular Oncology},
year = {2026},
doi = {10.1007/s13402-025-01131-z}
}
EUVIMED